UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

The High Court ruled on a significant patent dispute involving Pfizer and GSK, addressing costs and confidentiality.

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing informa ...

Marketing: Around the world, brands have learnt that revamping their identities without thinking the exercise through can be ...